ML20212L863

From kanterella
Revision as of 20:32, 27 July 2021 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Advisory Committee on the Medical Uses of Isotopes (ACMUI) September 21-22, 2020 Meeting Agenda
ML20212L863
Person / Time
Issue date: 07/30/2020
From:
Advisory Committee on the Medical Uses of Isotopes, Office of Nuclear Material Safety and Safeguards
To:
Jamerson, Kellee NMSS/MSST
References
Download: ML20212L863 (2)


Text

MEETING AGENDA ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES September 21-22, 2020 WEBEX NOTE: Sessions of the meeting may be closed pursuant to 5 U.S.C. 552(b) to discuss organizational and personnel matters that relate solely to internal personnel rules and practices of the ACMUI; information the release of which would constitute a clearly unwarranted invasion of personal privacy; information the premature disclosure of which would be likely to significantly frustrate implementation of a proposed agency action; and disclosure of information which would risk circumvention of an agency regulation or statute.

Monday, September 21, 2020 OPEN SESSION

1. Opening Remarks C. Einberg, NRC Mr. Einberg will formally open the meeting and provide opening remarks.
2. Old Business K. Jamerson, NRC Ms. Jamerson will review past ACMUI actions and recommendations 10:00 - 11:30 and provide NRC responses.
3. Open Forum ACMUI The ACMUI will identify medical topics of interest for further discussion.
4. Medical Events Subcommittee Report R. Ennis, ACMUI Dr. Ennis will provide an analysis of FY19 medical events.

11:30 - 12:15 BREAK/LUNCH

5. Non-Medical Events M. Sheetz, ACMUI Mr. Sheetz will provide an analysis of FY19 non-medical events reported by medical use facilities and commercial pharmacies.
6. New Drug Development and Labeling F. Lutterodt, FDA 12:15 - 2:00 Mr. Lutterodt will discuss the U.S. Food and Drug Administrations regulatory process for new drug development and labeling.
7. Dosimetry Methodology Update for Regulatory Guide 8.39, D. Hamby, Phase 2 Revision RCD Radiation Dr. Hamby will discuss the dosimetry methodology update for the Protection Assoc.

Regulatory Guide 8.39, Phase 2 revision.

2:00 ADJOURN FOR THE DAY Tuesday, September 22, 2020 CLOSED SESSION

8. INFOSEC Training R. Norman, NRC 10:00 - 12:00 9. Ethics Training C. Safford, NRC
10. Allegations Training S. Hawkins, NRC 1

12:00 - 12:15 BREAK Tuesday, September 22, 2020 OPEN SESSION

11. Medical Team Updates L. Dimmick, NRC Ms. Dimmick will provide an update on Medical Radiation Safety Team activities.

12:15 - 1:45 12. Open Forum ACMUI The ACMUI will discuss medical topics of interest previously identified.

13. Administrative Closing K. Jamerson, NRC Ms. Jamerson will provide a meeting summary and propose dates for the spring 2021 meeting.

1:45 ADJOURN 2